These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 38391356
1. Immunohistochemical expression of H3.3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India. Rekhi B, Dave V, Butle A, Dharavath B, Khetale S, Redhu AK, Singh R, Dutt A. Indian J Pathol Microbiol; 2024 Jul 01; 67(3):542-552. PubMed ID: 38391356 [Abstract] [Full Text] [Related]
2. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone. Yamamoto H, Iwasaki T, Yamada Y, Matsumoto Y, Otsuka H, Yoshimoto M, Kohashi K, Taguchi K, Yokoyama R, Nakashima Y, Oda Y. Hum Pathol; 2018 Mar 01; 73():41-50. PubMed ID: 29241742 [Abstract] [Full Text] [Related]
3. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India. Kamble A, Hui M, Rao KN, Narayanan R, Reddy BR, Uppin SG, Chandrasekhar P. Indian J Pathol Microbiol; 2022 Mar 01; 65(3):617-629. PubMed ID: 35900490 [Abstract] [Full Text] [Related]
9. Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of Bone. Miskad UA, Syamsul F, Dahlan H, Sungowati NK, Achmad D, Johan MP. Asian Pac J Cancer Prev; 2023 May 01; 24(5):1737-1741. PubMed ID: 37247296 [Abstract] [Full Text] [Related]
10. Reliability and Role of Mutation-specific H3F3A (Histone 3-3) G34W Immunohistochemistry to Differentiate Giant Cell Tumor of Bone From its Clinicoradiologic and Histologic Mimics: An Institutional Study. Pasricha S, Pruthi M, Jajodia A, Kumar A, Gupta G, Sharma A, Tiwari A, Rohela H, Durga G, Kamboj M, Koyyala VPB, Mehta A. Appl Immunohistochem Mol Morphol; 2022 Jan 01; 30(1):36-41. PubMed ID: 34347625 [Abstract] [Full Text] [Related]
11. Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases. Yang L, Zhang H, Zhang X, Tang Y, Wu Z, Wang Y, Huang H, Fu X, Liu J, Hogendoorn PCW, Cheng H. Ann Diagn Pathol; 2022 Apr 01; 57():151882. PubMed ID: 34995868 [Abstract] [Full Text] [Related]
12. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology. Yamamoto H, Ishihara S, Toda Y, Oda Y. Med Mol Morphol; 2020 Mar 01; 53(1):1-6. PubMed ID: 31748824 [Abstract] [Full Text] [Related]
13. Diagnostic Utility of Genetic and Immunohistochemical H3-3A Mutation Analysis in Giant Cell Tumour of Bone. Wągrodzki M, Tysarowski A, Seliga K, Wojnowska A, Stepaniuk M, Castañeda Wysocka P, Makuła D, Pieńkowski A, Szostakowski B, Zub R, Rutkowski P. Int J Mol Sci; 2022 Jan 16; 23(2):. PubMed ID: 35055156 [Abstract] [Full Text] [Related]
18. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma. Cleven AH, Höcker S, Briaire-de Bruijn I, Szuhai K, Cleton-Jansen AM, Bovée JV. Am J Surg Pathol; 2015 Nov 16; 39(11):1576-83. PubMed ID: 26457357 [Abstract] [Full Text] [Related]
19. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases. Leinauer B, Wolf E, Werner M, Baumhoer D, Breining T, Luebke AM, Maas R, Schultheiß M, von Baer A, Sufi-Siavach A, Moritz C, Geißler S, Mellert K, Möller P, Barth TFE, Jundt G. Histopathology; 2021 Nov 16; 79(5):720-730. PubMed ID: 33991114 [Abstract] [Full Text] [Related]
20. Anti-histone H3.3K36M Antibody is a Highly Sensitive and Specific Immunohistochemistry Marker for the Diagnosis of Chondroblastoma. A Validation Based on Study 136 Cases Comprising Chondroblastoma and its Mimics from Single a Centre in India. Hui M, Uppin SG, Narayanan R, Kancherla NR, Kamble A, B RR, Patnala C. Int J Surg Pathol; 2023 Jun 16; 31(4):375-386. PubMed ID: 35786027 [Abstract] [Full Text] [Related] Page: [Next] [New Search]